Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/?
B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi
|
abnormal snout skin morphology |
J:252837
|
|
calcified skin |
J:252837
|
|
calcinosis |
J:252837
|
Abcc6tm1c(EUCOMM)Wtsi/Abcc6tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/?
Speer6-ps1Tg(Alb-cre)21Mgn/?
B6.Cg-E2f1Tg(Wnt1-cre)2Sor Abcc6tm1c(EUCOMM)Wtsi Speer6-ps1Tg(Alb-cre)21Mgn
|
abnormal snout skin morphology |
J:252837
|
|
calcified skin |
J:252837
|
|
calcinosis |
J:252837
|
Ankrd11tm1c(EUCOMM)Wtsi/Ankrd11+
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6 * C57BL/6N
|
abnormal frontal bone morphology |
J:306391
|
|
abnormal mandible morphology |
J:306391
|
|
abnormal midface morphology |
J:306391
|
|
abnormal neurocranium morphology |
J:306391
|
|
abnormal nose morphology |
J:306391
|
|
abnormal pterygoid bone morphology |
J:306391
|
|
enlarged neurocranium |
J:306391
|
|
large anterior fontanelle |
J:306391
|
|
midface hypoplasia |
J:306391
|
|
normal
mortality/aging |
J:306391
|
|
narrow face |
J:306391
|
|
wide metopic suture |
J:306391
|
Ankrd11tm1c(EUCOMM)Wtsi/Ankrd11tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6 * C57BL/6N
|
abnormal basicranium morphology |
J:306391
|
|
abnormal bone collagen fibril morphology |
J:306391
|
|
abnormal bone remodeling |
J:306391
|
|
abnormal cranial blood vasculature morphology |
J:306391
|
|
abnormal craniofacial morphology |
J:306391
|
|
abnormal head morphology |
J:306391
|
|
abnormal intramembranous bone ossification |
J:306391
|
|
abnormal neurocranium morphology |
J:306391
|
|
abnormal osteocyte morphology |
J:306391
|
|
abnormal palatal mesenchymal cell proliferation |
J:306391
|
|
abnormal palatal shelf morphology |
J:306391
|
|
abnormal palatine bone morphology |
J:306391
|
|
abnormal snout skin morphology |
J:306391
|
|
absent pterygoid process |
J:306391
|
|
cleft hard palate |
J:306391
|
|
cleft palate |
J:306391
|
|
decreased bone ossification |
J:306391
|
|
decreased bone resorption |
J:306391
|
|
decreased bone trabecula number |
J:306391
|
|
decreased osteoclast cell number |
J:306391
|
|
decreased tongue size |
J:306391
|
|
delayed intramembranous bone ossification |
J:306391
|
|
domed cranium |
J:306391
|
|
eyelids open at birth |
J:306391
|
|
frontal bone hypoplasia |
J:306391
|
|
hypopigmentation |
J:306391
|
|
impaired ossification of basisphenoid bone |
J:306391
|
|
large anterior fontanelle |
J:306391
|
|
micrognathia |
J:306391
|
|
midface hypoplasia |
J:306391
|
|
palatal shelf hypoplasia |
J:306391
|
|
palatal shelves fail to meet at midline |
J:306391
|
|
perinatal lethality, complete penetrance |
J:306391
|
|
retrognathia |
J:306391
|
|
short tongue |
J:306391
|
|
small frontal bone |
J:306391
|
|
small mandible |
J:306391
|
|
small parietal bone |
J:306391
|
|
tongue hypoplasia |
J:306391
|
|
triangular face |
J:306391
|
C2cd3em2Brgm/C2cd3em2Brgm
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6
|
abnormal cilium physiology |
J:308674
|
|
abnormal tongue morphology |
J:308674
|
|
cleft palate |
J:308674
|
|
delayed bone ossification |
J:308674
|
C2cd3tm1c(EUCOMM)Wtsi/C2cd3tm1c(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6
|
abnormal cilium physiology |
J:308674
|
|
abnormal facial morphology |
J:308674
|
|
cleft palate |
J:308674
|
|
delayed bone ossification |
J:308674
|
|
tongue hypoplasia |
J:308674
|
Chd7tm2a(EUCOMM)Wtsi/Chd7tm2a(EUCOMM)Wtsi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
involves: 129 * C3H * C57BL/6 * C57BL/6N
|
abnormal conotruncal ridge morphology |
J:298597
|
|
abnormal cranial neural crest cell migration |
J:298597
|
|
abnormal embryonic tissue physiology |
J:298597
|
|
abnormal pharyngeal arch morphology |
J:298597
|
|
double outlet right ventricle |
J:298597
|
|
impaired cranial neural crest cell differentiation |
J:298597
|
|
interrupted aortic arch, type b |
J:298597
|
|
perinatal lethality, complete penetrance |
J:298597
|
|
pulmonary trunk hypoplasia |
J:298597
|
|
small frontal bone |
J:298597
|
|
small mandible |
J:298597
|
|
small maxilla |
J:298597
|
|
ventricular septal defect |
J:298597
|
E2f1Tg(Wnt1-cre)2Sor/E2f1+
Snrpbem1Lajm/Snrpb+
involves: C3H * C57BL/6 * C57BL/6J * CD1
|
abnormal cranial ganglia morphology |
J:326544
|
|
abnormal cranium morphology |
J:326544
|
|
abnormal DNA-templated transcription |
J:326544
|
|
abnormal embryonic tissue morphology |
J:326544
|
|
abnormal forebrain morphology |
J:326544
|
|
abnormal frontonasal prominence morphology |
J:326544
|
|
abnormal geniculate ganglion morphology |
J:326544
|
|
abnormal glossopharyngeal nerve morphology |
J:326544
|
|
abnormal head development |
J:326544
|
|
abnormal head shape |
J:326544
|
|
abnormal jaw morphology |
J:326544
|
|
abnormal mandible morphology |
J:326544
|
|
abnormal mandibular nerve morphology |
J:326544
|
|
abnormal maxillary nerve morphology |
J:326544
|
|
abnormal metopic suture morphology |
J:326544
|
|
abnormal nasopharynx morphology |
J:326544
|
|
abnormal nose morphology |
J:326544
|
|
abnormal ophthalmic nerve morphology |
J:326544
|
|
abnormal premaxilla morphology |
J:326544
|
|
abnormal temporal bone morphology |
J:326544
|
|
abnormal tracheal cartilage morphology |
J:326544
|
|
abnormal trigeminal nerve morphology |
J:326544
|
|
abnormal vagus nerve morphology |
J:326544
|
|
abnormal vestibular ganglion morphology |
J:326544
|
|
absent alisphenoid bone |
J:326544
|
|
absent aorticopulmonary septum |
J:326544
|
|
absent frontonasal prominence |
J:326544
|
|
absent gastric milk in neonates |
J:326544
|
|
absent hyoid bone |
J:326544
|
|
absent mandibular angle |
J:326544
|
|
absent mandibular condyloid process |
J:326544
|
|
absent mandibular coronoid process |
J:326544
|
|
absent maxillary prominence |
J:326544
|
|
absent nasal septum |
J:326544
|
|
absent tympanic ring |
J:326544
|
|
absent zygomatic arch |
J:326544
|
|
athymia |
J:326544
|
|
basisphenoid bone hypoplasia |
J:326544
|
|
cleft palate |
J:326544
|
|
domed cranium |
J:326544
|
|
ectopic bone |
J:326544
|
|
ectopic cartilage |
J:326544
|
|
edema |
J:326544
|
|
enlarged lateral ventricles |
J:326544
|
|
first pharyngeal arch hypoplasia |
J:326544
|
|
frontal bone hypoplasia |
J:326544
|
|
frontonasal prominence hypoplasia |
J:326544
|
|
hindbrain hypoplasia |
J:326544
|
|
hyoid bone hypoplasia |
J:326544
|
|
interparietal bone hypoplasia |
J:326544
|
|
lethality throughout fetal growth and development, incomplete penetrance |
J:326544
|
|
mandible hypoplasia |
J:326544
|
|
mandibular prominence hypoplasia |
J:326544
|
|
maxilla hypoplasia |
J:326544
|
|
maxillary prominence hypoplasia |
J:326544
|
|
Meckel's cartilage hypoplasia |
J:326544
|
|
midbrain hypoplasia |
J:326544
|
|
nasal bone hypoplasia |
J:326544
|
|
neonatal lethality, complete penetrance |
J:326544
|
|
parietal bone hypoplasia |
J:326544
|
|
pharyngeal arch hypoplasia |
J:326544
|
|
short snout |
J:326544
|
|
small dorsal root ganglion |
J:326544
|
|
small ears |
J:326544
|
|
small temporal bone squamous part |
J:326544
|
|
thin cerebral cortex |
J:326544
|
E2f1Tg(Wnt1-cre)2Sor/E2f1+
Snrpbem1Lajm/Snrpb+
Trp53tm1Brn/Trp53+
involves: 129P2/OlaHsd * C3H * C57BL/6 * CD1
|
abnormal craniofacial morphology |
J:326544
|
E2f1Tg(Wnt1-cre)2Sor/E2f1+
Snrpbem1Lajm/Snrpb+
Trp53tm1Brn/Trp53tm1Brn
involves: 129P2/OlaHsd * C3H * C57BL/6 * CD1
|
abnormal bone ossification |
J:326544
|
|
abnormal mandible morphology |
J:326544
|
|
cleft palate |
J:326544
|
|
microcephaly |
J:326544
|
|
micrognathia |
J:326544
|
|
perinatal lethality, complete penetrance |
J:326544
|
|
short snout |
J:326544
|
E2f1tm1Meg/E2f1+
Rbl1tm1Htr/Rbl1tm1Htr
Tg(Pax6-cre,GFP)2Pgr/?
involves: 129 * C57BL/6 * FVB/N * NMRI
|
abnormal eye development |
J:124204
|
E2f1tm1Meg/E2f1+
Phactr4humdy/Phactr4humdy
involves: 129S4/SvJae * C57BL/6J
|
exencephaly |
J:123924
|
|
normal
vision/eye phenotype |
J:123924
|
E2f1tm1Meg/E2f1+
Tg(CAG-Tfb1m)AGsha/0
involves: 129S4/SvJae * C57BL/6J * SJL/J
|
normal
hearing/vestibular/ear phenotype |
J:181548
|
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm2.1Gle/E2f3tm2.1Gle
involves: 129 * FVB/N * NIH Black Swiss
|
decreased cell proliferation |
J:138289
|
|
perinatal lethality |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
E2f2tm1Zubi/E2f2tm1Zubi
E2f3tm3.1Gle/E2f3tm3.1Gle
involves: 129 * FVB/N * NIH Black Swiss
|
decreased body weight |
J:138289
|
|
decreased cell proliferation |
J:138289
|
|
normal
mortality/aging |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
E2f3tm1.1Gle/E2f3tm1.1Gle
Rbl1tm1Htr/Rbl1tm1Htr
Tg(Pax6-cre,GFP)2Pgr/?
involves: 129 * C57BL/6 * FVB/N * NMRI
|
normal
vision/eye phenotype |
J:124204
|
E2f1tm1Meg/E2f1tm1Meg
E2f3tm2.1Gle/E2f3tm2.1Gle
involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss
|
abnormal adrenal cortex morphology |
J:138289
|
|
abnormal brain size |
J:138289
|
|
abnormal corpus luteum morphology |
J:138289
|
|
abnormal epiphyseal plate morphology |
J:138289
|
|
abnormal lung epithelium morphology |
J:138289
|
|
normal
adipose tissue phenotype |
J:138289
|
|
normal
behavior/neurological phenotype |
J:138289
|
|
decreased body size |
J:138289
|
|
decreased body weight |
J:138289
|
|
decreased cell proliferation |
J:138289
|
|
decreased circulating growth hormone level |
J:138289
|
|
decreased circulating insulin-like growth factor I level |
J:138289
|
|
decreased circulating leptin level |
J:138289
|
|
decreased circulating triglyceride level |
J:138289
|
|
decreased survivor rate |
J:138289
|
|
decreased white adipose tissue amount |
J:138289
|
|
normal
digestive/alimentary phenotype |
J:138289
|
|
female infertility |
J:138289
|
|
male infertility |
J:138289
|
|
ovary hypoplasia |
J:138289
|
|
premature death |
J:138289
|
|
testis hypoplasia |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
E2f3tm3.1Gle/E2f3tm3.1Gle
involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss
|
decreased body weight |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
E2f3tm4Gle/E2f3tm4Gle
involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss
|
no abnormal phenotype detected |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
E2f3tm5(E2f1)Gle/E2f3tm5(E2f1)Gle
involves: 129S4/SvJae * 129S6/SvEvTac * FVB/N * NIH Black Swiss
|
no abnormal phenotype detected |
J:138289
|
E2f1tm1Meg/E2f1tm1Meg
H2-Oa/Brd2Tg(otx2-lacZ)F5pImat/H2-Oa/Brd2Tg(otx2-lacZ)F5pImat
involves: 129S4/SvJae * CD-1
|
normal
embryo phenotype |
J:188139
|
|
normal
nervous system phenotype |
J:188139
|
E2f1tm1Meg/E2f1tm1Meg
Phactr4humdy/Phactr4humdy
involves: 129S4/SvJae * C57BL/6J
|
exencephaly |
J:123924
|
|
normal
vision/eye phenotype |
J:123924
|
E2f1tm1Meg/E2f1tm1Meg
Rb1tm1Tyj/Rb1tm1Tyj
Tg(Rb1)1Blg/0
involves: 129S2/SvPas * 129S4/SvJae
|
abnormal cell cycle |
J:65679
|
|
abnormal muscle physiology |
J:65679
|
|
abnormal skeletal muscle fiber morphology |
J:65679
|
|
hunched posture |
J:65679
|
|
hyporesponsive to tactile stimuli |
J:65679
|
|
polyploidy |
J:65679
|
E2f1tm1Meg/E2f1tm1Meg
Rb1tm2.1Fad/Rb1tm2.1Fad
involves: 129S4/SvJae * C57BL/6
|
normal
cellular phenotype |
J:215358
|
|
normal
neoplasm |
J:215358
|
|
postnatal lethality, incomplete penetrance |
J:215358
|
E2f1tm1Meg/E2f1tm1Meg
Rbl1tm1Htr/Rbl1tm1Htr
Tg(Pax6-cre,GFP)2Pgr/?
involves: 129 * C57BL/6 * FVB/N * NMRI
|
abnormal amacrine cell morphology |
J:124204
|
|
abnormal cone electrophysiology |
J:124204
|
|
abnormal retina bipolar cell morphology |
J:124204
|
|
abnormal retina inner plexiform layer morphology |
J:124204
|
|
abnormal retina morphology |
J:124204
|
|
decreased retina ganglion cell number |
J:124204
|
|
thin retina outer nuclear layer |
J:124204
|
E2f1tm1Njd/E2f1+
Rb1tm1Tyj/Rb1+
either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)
|
increased thyroid adenoma incidence |
J:47108
|
|
increased tumor incidence |
J:47108
|
|
premature death |
J:47108
|
E2f1tm1Njd/E2f1+
Rb1tm1Tyj/Rb1tm1Tyj
either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)
|
prenatal lethality, complete penetrance |
J:47108
|
E2f1tm1Njd/E2f1+
E2f3tm1Lees/E2f3tm1Lees
involves: 129S2/SvPas
|
lethality throughout fetal growth and development, complete penetrance |
J:75765
|
E2f1tm1Njd/E2f1tm1Njd
E2f3tm1Lees/E2f3+
involves: 129S2/SvPas
|
slow postnatal weight gain |
J:75765
|
|
testicular atrophy |
J:75765
|
E2f1tm1Njd/E2f1tm1Njd
E2f3tm1Lees/E2f3tm1Lees
involves: 129S2/SvPas
|
embryonic lethality during organogenesis, complete penetrance |
J:75765
|
E2f1tm1Njd/E2f1tm1Njd
E2f3tm2Lees/E2f3tm2Lees
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
|
abnormal cartilage morphology |
J:147270
|
|
abnormal cell cycle |
J:147270
|
|
abnormal chondrocyte morphology |
J:147270
|
|
abnormal long bone epiphyseal plate morphology |
J:147270
|
|
decreased body weight |
J:147270
|
|
decreased cell proliferation |
J:147270
|
|
neonatal lethality, incomplete penetrance |
J:147270
|
E2f1tm1Njd/E2f1tm1Njd
E2f3tm3Lees/E2f3tm3Lees
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
|
no abnormal phenotype detected |
J:147270
|
E2f1tm1Njd/E2f1tm1Njd
Klhl40tm1.1Itl/Klhl40tm1.1Itl
involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6N
|
decreased body size |
J:227534
|
|
normal
mortality/aging |
J:227534
|
E2f1tm1Njd/E2f1tm1Njd
Rb1tm1Tyj/Rb1+
either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)
|
abnormal thyroid gland morphology |
J:47108
|
|
adrenal medulla hyperplasia |
J:47108
|
|
increased hemangioma incidence |
J:47108
|
|
increased pituitary gland tumor incidence |
J:47108
|
|
increased thyroid adenoma incidence |
J:47108
|
|
premature death |
J:47108
|
|
uterine hemorrhage |
J:47108
|
E2f1tm1Njd/E2f1tm1Njd
Rb1tm1Tyj/Rb1tm1Tyj
either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)
|
prenatal lethality, complete penetrance |
J:47108
|
E2f1tm1Njd/E2f1tm1Njd
Trp53tm1Brd/Trp53tm1Brd
involves: 129S2/SvPas * 129S7/SvEvBrd * SKH1
|
increased sensitivity to skin irradiation |
J:97525
|
H2-Oa/Brd2Tg(otx2-lacZ)F5pImat/H2-Oa/Brd2Tg(otx2-lacZ)F5pImat
E2f1tm1Meg/E2f1tm1Meg
involves: 129S4/SvJae * CD-1
|
normal
embryo phenotype |
J:188139
|
|
normal
nervous system phenotype |
J:188139
|
Hand1tm2Eno/Hand1tm3Abfi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S6/SvEvTac * C3H * C57BL/6
|
abnormal craniofacial development |
J:214092
|
|
abnormal maxillary prominence morphology |
J:214092
|
|
abnormal nasal capsule morphology |
J:214092
|
|
abnormal palatal shelf fusion at midline |
J:214092
|
|
abnormal pharyngeal arch morphology |
J:214092
|
|
abnormal secondary palate development |
J:214092
|
|
abnormal tongue position |
J:214092
|
|
absent nasal septum |
J:214092
|
|
basisphenoid bone hypoplasia |
J:214092
|
|
midline facial cleft |
J:214092
|
|
nasal bone hypoplasia |
J:214092
|
|
neonatal lethality |
J:214092
|
Hand1tm2Eno/Hand1tm4Abfi
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S6/SvEvTac * C3H * C57BL/6
|
abnormal craniofacial development |
J:214092
|
|
abnormal maxillary prominence morphology |
J:214092
|
|
abnormal nasal capsule morphology |
J:214092
|
|
abnormal palatal shelf fusion at midline |
J:214092
|
|
abnormal pharyngeal arch morphology |
J:214092
|
|
abnormal secondary palate development |
J:214092
|
|
absent middle ear ossicles |
J:214092
|
|
absent nasal septum |
J:214092
|
|
decreased maxillary shelf size |
J:214092
|
|
decreased palatine bone horizontal plate size |
J:214092
|
|
mandible hypoplasia |
J:214092
|
|
middle ear ossicle hypoplasia |
J:214092
|
|
midline facial cleft |
J:214092
|
|
neonatal lethality |
J:214092
|
|
temporal bone squamous part hypoplasia |
J:214092
|
Hand1tm3Abfi/Hand1+
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6
|
abnormal alisphenoid bone morphology |
J:214092
|
|
abnormal basicranium morphology |
J:214092
|
|
abnormal maxilla morphology |
J:214092
|
|
abnormal nasal capsule morphology |
J:214092
|
|
abnormal palatal shelf fusion at midline |
J:214092
|
|
abnormal pharyngeal arch morphology |
J:214092
|
|
abnormal Reichert's cartilage morphology |
J:214092
|
|
abnormal sagittal suture morphology |
J:214092
|
|
abnormal secondary palate development |
J:214092
|
|
abnormal tongue position |
J:214092
|
|
absent nasal bone |
J:214092
|
|
absent nasal septum |
J:214092
|
|
absent temporal bone squamous part |
J:214092
|
|
basisphenoid bone hypoplasia |
J:214092
|
|
frontal bone hypoplasia |
J:214092
|
|
interparietal bone hypoplasia |
J:214092
|
|
mandible hypoplasia |
J:214092
|
|
midline facial cleft |
J:214092
|
|
neonatal lethality |
J:214092
|
|
pterygoid bone hypoplasia |
J:214092
|
|
short Meckel's cartilage |
J:214092
|
|
short premaxilla |
J:214092
|
|
zygomatic bone hypoplasia |
J:214092
|
Hand1tm4Abfi/Hand1+
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: C3H * C57BL/6
|
abnormal alisphenoid bone morphology |
J:214092
|
|
abnormal nasal capsule morphology |
J:214092
|
|
abnormal palatal shelf fusion at midline |
J:214092
|
|
abnormal pharyngeal arch morphology |
J:214092
|
|
abnormal tongue position |
J:214092
|
|
absent nasal septum |
J:214092
|
|
midline facial cleft |
J:214092
|
|
nasal bone hypoplasia |
J:214092
|
|
neonatal lethality |
J:214092
|
|
premaxilla hypoplasia |
J:214092
|
|
small mandible |
J:214092
|
|
temporal bone squamous part hypoplasia |
J:214092
|
Mmachcem1Poche/Mmachcem1Poche
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S4/SvJae * C3H * C57BL/6 * C57BL/6J
|
normal
craniofacial phenotype |
J:317822
|
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6J
|
abnormal craniofacial bone morphology |
J:279139
|
|
abnormal frontal bone morphology |
J:279139
|
|
abnormal nasal bone morphology |
J:279139
|
|
abnormal palatal mesenchymal cell proliferation |
J:279139
|
|
absent palatine bone horizontal plate |
J:279139
|
|
normal
cardiovascular system phenotype |
J:279139
|
|
cleft secondary palate |
J:279139
|
|
decreased bone ossification |
J:279139
|
|
normal
endocrine/exocrine gland phenotype |
J:279139
|
|
frontal bone hypoplasia |
J:279139
|
|
neonatal lethality, complete penetrance |
J:279139
|
|
palatal shelves fail to meet at midline |
J:279139
|
|
normal
skeleton phenotype |
J:279139
|
|
small mandible |
J:279139
|
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
E2f1Tg(Wnt1-cre)2Sor/E2f1+
Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/Gt(ROSA)26Sor+
involves: 129S/Sv * 129X1/SvJ * C57BL/6J
|
normal
cellular phenotype |
J:279139
|
|
normal
embryo phenotype |
J:279139
|
Sox9tm2Crm/Sox9+
Rr80em1Jwsk/Rr80+
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S7/SvEvBrd * C3H * C57BL/6J * FVB/NJ
|
abnormal mandible morphology |
J:306395
|
|
mandibular condyloid process hypoplasia |
J:306395
|
|
postnatal growth retardation |
J:306395
|
|
short mandible |
J:306395
|
Tg(ACTB-Edn1)721Clou/0
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S4/SvJae * C3H * C57BL/6
|
abnormal mandible morphology |
J:221133
|
|
abnormal Meckel's cartilage morphology |
J:221133
|
|
abnormal temporal bone squamous part morphology |
J:221133
|
|
absent palatine bone |
J:221133
|
|
absent zygomatic bone |
J:221133
|
|
basisphenoid bone hypoplasia |
J:221133
|
|
cleft palate |
J:221133
|
|
midline facial cleft |
J:221133
|
|
upper jaw to lower jaw transformation |
J:221133
|
Tg(ACTB-Edn1)1398Clou/0
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S4/SvJae * C3H * C57BL/6
|
abnormal incus morphology |
J:221133
|
|
abnormal malleus morphology |
J:221133
|
|
abnormal mandibular angle morphology |
J:221133
|
|
abnormal tympanic ring morphology |
J:221133
|
|
abnormal zygomatic bone morphology |
J:221133
|
|
absent mandibular coronoid process |
J:221133
|
|
cleft palate |
J:221133
|
|
ectopic cranial bone |
J:221133
|
|
gonial bone hypoplasia |
J:221133
|
|
palatine bone hypoplasia |
J:221133
|
|
temporal bone squamous part hypoplasia |
J:221133
|
|
upper jaw to lower jaw transformation |
J:221133
|
Tg(ACTB-Edn1)1408Clou/0
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S4/SvJae * C3H * C57BL/6
|
normal
craniofacial phenotype |
J:221133
|
Tg(ACTB-Edn1)1416Clou/0
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S4/SvJae * C3H * C57BL/6
|
abnormal mandibular angle morphology |
J:221133
|
|
abnormal Meckel's cartilage morphology |
J:221133
|
|
abnormal tympanic ring morphology |
J:221133
|
|
absent mandibular coronoid process |
J:221133
|
|
ectopic cartilage |
J:221133
|
|
malleus hypoplasia |
J:221133
|
|
midline facial cleft |
J:221133
|
|
palatine bone hypoplasia |
J:221133
|
|
temporal bone squamous part hypoplasia |
J:221133
|
|
upper jaw to lower jaw transformation |
J:221133
|
Thap11tm1Tpz/Thap11em1Poche
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J
|
belly spot |
J:317822
|
|
decreased digit pigmentation |
J:317822
|
Thap11tm1Tpz/Thap11tm1Tpz
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C3H * C57BL/6
|
abnormal craniofacial development |
J:317822
|
Vegfatm2Gne/Vegfatm2Gne
E2f1Tg(Wnt1-cre)2Sor/E2f1+
involves: 129/Sv * C3H * C57BL/6
|
abnormal intramembranous bone ossification |
J:309228
|
|
abnormal mandible morphology |
J:309228
|
|
abnormal maxilla morphology |
J:309228
|
|
abnormal palatal mesenchymal cell proliferation |
J:309228
|
|
abnormal palatal shelf bone ossification |
J:309228
|
|
abnormal palatal shelf elevation |
J:309228
|
|
abnormal secondary palate development |
J:309228
|
|
abnormal vascular development |
J:309228
|
|
decreased palatal shelf size |
J:309228
|
|
palatal shelf hypoplasia |
J:309228
|
|
palatal shelves fail to meet at midline |
J:309228
|
|
poor arterial differentiation |
J:309228
|
Excel File
Analysis Tools